Camurus has now become cash flow positive, with the ability to fund future projects on its own, which to us makes it ...
Researchers have discovered that not all atoms in a liquid are in motion and that some remain stationary regardless of the temperature, significantly impacting the solidification process, including ...
B7H3 and PTK7 is co-expressed in multiple solid tumor types, including lung, colorectal, and head and neck cancers, at approximately 30%, 46%, and 27%, respectively Deep and durable regressions ...
China may have just had multiple breakthroughs in EV battery technology with new solid-state battery tech that could offer more than 600 miles of range and weigh at 220 lbs. For reference, batteries ...
Konami has patched Metal Gear Solid Delta: Snake Eater for PS5, PC, and Xbox Series X/S, which comes with a number of key bug fixes for the stealth-action title. The update comes following news that ...
South Korean battery giant SK On has started the trial production of all-solid-state batteries. The company said it was using a unique process to make the electrodes reliably on an automated ...
Rezatapopt demonstrated a 33% overall response rate in tumors with TP53 Y220C mutations, with a median response duration of 6.2 months. The phase 2 PYNNACLE trial reported consistent safety results ...
Nikesh Kooverjee has been contributing to the automotive sphere for 11 years. His previous roles include Digital Editor at CAR South Africa and associate editor at CarBuzz. He has always had a strong ...
Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death. By Gina Kolata A ...
Today some of the most aggressive solid tumor cancers remain stubbornly resistant to treatment. There are many reasons why these cancers are difficult to treat, including mutations they may express or ...
Bristol Myers BMY announced that the European Commission (EC) has approved the subcutaneous formulation of Opdivo (nivolumab) across multiple solid tumor indications. The decision applies to all 27 EU ...